Liver Damage Worries Lead To Further EU Restrictions On Richter’s Esmya

 
• By Ian Schofield

The European Medicines Agency’s pharmacovigilance committee has recommended more restrictions on the use of Richter’s Esmya because of concerns over the risk of serious liver damage.

Liver
The EMA has placed new restrictions on Esmya because of liver safety concerns

More from Drug Safety

More from Pink Sheet